Redox regulation of human adenylate kinase 2 (AK2), an essential key controller of energy metabolism
Redox regulation of human adenylate kinase 2 (AK2), an essential key controller of energy metabolism
批准号:
251546152
负责人:
Professor Dr. Jan Riemer
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2014
资助国家:
德国
项目状态:
已结题
起止时间:
2013-12-31 至 2020-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The mitochondrial intermembrane space (IMS) takes a critical role in mitochondrial physiology. IMS proteins are involved in important metabolic processes, protein import and folding, signaling events and the initiation of apoptosis. By characterising the substrate spectrum of import pathways into the IMS, we identified adenylate kinase 2 (AK2) as target of the IMS disulphide formation machinery. AK2 is an essential protein that controls energy metabolism and AMPK-dependent signaling. Patients lacking this enzyme suffer from a fatal immunodeficiency due to an arrest in the differentiation of certain immune cells. Interestingly, nothing is known about the mechanisms of mitochondrial AK2 import and its regulation as well as the regulation of its activity once it has matured in the IMS. Our preliminary data suggest that AK2 is the target of the IMS import receptor and oxidoreductase CHCHD4/Mia40. Moreover, redox-dependent AK2 import appears to be controlled by a cytosolic quality control machinery that minimizes cytosolic mislocalisation of AK2. Lastly, AK2 also appears to be subject to thiol-disulfide-dependent redox regulation in the IMS. The aim of this project is to understand in molecular detail these two processes and obtain insights into the physiological consequences of a failure of these processes. Our findings will thereby help to better understand cellular energy metabolism as well as the signaling network that controls it.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mia40 and ALR substrates: initial steps in biogenesis and regulation
-
批准号:196651114
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Professor Dr. Jan Riemer
-
依托单位:
NOVEL TARGETS OF THE SULFHYDRYL : CYTOCHROME C OXIDOREDUCTASE ALR
-
批准号:435235019
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Jan Riemer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
-
批准号:82371770
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:宁铂涛
-
依托单位:
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
亚低温调控颅脑创伤急性期神经干细胞Mpc2/Lactate/H3K9lac通路促进神经修复的研究
-
批准号:82371379
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:冯军峰
-
依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
-
批准号:82371150
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯书乐
-
依托单位:
mPFC-VTA-NAc多巴胺能投射调控丙泊酚麻醉—觉醒的机制研究
-
批准号:82371284
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:许涛
-
依托单位: